COOKIES OP www.astrealaw.be

Astrea gebruikt cookies om er voor te zorgen dat bezoekers op de meest optimale manier gebruik kunnen maken van de toepassingen van deze website. Cookies kunnen ook gebruikt worden om bezoekersgedrag op anonieme wijze te meten en te analyseren en om de inhoud van de website te verbeteren. Bemerk dat indien u geen cookies wenst te aanvaarden, het mogelijk is dat bepaalde toepassingen op deze website door u niet of niet optimaal toegankelijk zijn.

Print Friendly and PDF NL | FR | EN | DE

COVID-19 AND ITS IMPACT ON M&A IN BELGIUM

14.4.2020

Parties which are currently negotiating M&A transactions or envisage to enter into negotiations about such transactions in Belgium must assess the impact of COVID-19 on their deals.

Astrea discusses in its memo “Covid-19 and its impact on M&A in Belgium” the most important aspects of M&A in COVID-19 times in Belgium such as the increased focus on certain matters during due diligence process, potential material adverse changes (MAC/MAE) that may block the deal, interim operating covenants or acquisition finance.

 

 

COVID-19 AND ITS IMPACT ON M&A IN BELGIUM

Parties which are currently negotiating M&A transactions or envisage to enter into negotiations about such transactions in Belgium must assess the impact of COVID-19 on their deals.

Astrea discusses in its memo “Covid-19 and its impact on M&A in Belgium” the most important aspects of M&A in COVID-19 times in Belgium such as the increased focus on certain matters during due diligence process, potential material adverse changes (MAC/MAE) that may block the deal, interim operating covenants or acquisition finance.